E — Eni S.p.A. — BullishAgent

E

Eni S.p.A. NYSE

Energy ·Oil & Gas Integrated ·IT · eni.com

$56.19

Mkt Cap $82.8B

52w Low $28.42 93.9% of range 52w High $58.00

50d MA $52.29 200d MA $40.72

P/E (TTM) 32.6x

EV/EBITDA 5.5x

P/B 1.8x

Debt/Equity 0.9x

ROE —

P/FCF 10.6x

RSI (14) —

ATR (14) —

Beta 0.26

50d MA $52.29

200d MA $40.72

Avg Volume 545.7K

About

Eni S.p.A. engages in the exploration, development, and production of crude oil and natural gas. It operates through Exploration & Production; Global Gas & LNG Portfolio; Refining & Marketing and Chemicals; Plenitude and Power; and Corporate and Other activities segments. The Exploration & Production segment is involved in the research, development, and production of oil, condensates and natural g…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Apr 24, 2026	TNS	1.13	0.81	-28.3%	54.11	-0.5%	-0.6%	+1.3%	+2.5%	+4.7%	+3.8%	—	—
Feb 26, 2026	TNS	0.78	0.87	+11.5%	45.54	+2.7%	+3.1%	+4.0%	+1.5%	+2.7%	+2.4%	+22.5%	—
Oct 24, 2025	TNS	0.73	0.90	+23.3%	36.81	+0.3%	+0.7%	+0.8%	+0.9%	-0.4%	+0.3%	+0.4%	—
Jul 25, 2025	TNS	0.67	0.79	+17.9%	34.69	-1.2%	-1.1%	-0.3%	-1.8%	-1.9%	-2.1%	+2.6%	—
Apr 24, 2025	TNS	0.91	0.92	+1.1%	28.86	-0.2%	+0.7%	+0.6%	-0.2%	-1.6%	-0.4%	+2.6%	—
Feb 27, 2025	TNS	0.84	0.58	-31.0%	29.21	-1.9%	-0.8%	-2.3%	-3.8%	-2.5%	-2.1%	+5.9%	—
Oct 25, 2024	TNS	0.89	0.86	-3.4%	31.00	-2.1%	-1.8%	-2.8%	-2.4%	-1.8%	-2.3%	-7.6%	—
Jul 26, 2024	TNS	1.12	0.98	-12.5%	31.66	+0.2%	+0.3%	+0.3%	+1.2%	-0.8%	-2.2%	+3.9%	—
Apr 24, 2024	TNS	1.22	1.04	-14.8%	32.59	+0.3%	+0.6%	+0.6%	+0.6%	-1.7%	-2.7%	-4.4%	—
Feb 19, 2024	TNS	1.22	1.06	-13.1%	—	—	—	—	—	—	—	—	—
Oct 27, 2023	TNS	1.16	1.18	+1.7%	32.46	+2.3%	+0.2%	+0.3%	+0.8%	+2.8%	+1.0%	+0.9%	—
Jul 28, 2023	TNS	1.15	1.24	+7.8%	30.18	+1.7%	+1.6%	+0.9%	-1.5%	-0.6%	-0.3%	+2.3%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 9	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$55.31	$56.49	+2.1%	+0.7%	+2.0%	+1.3%	+0.1%	-2.0%
Mar 2	JP Morgan	Upgrade	Underweight → Overweight	—	$46.94	$47.70	+1.6%	+0.9%	-1.5%	-0.3%	-0.6%	+1.7%
Dec 5	JP Morgan	Downgrade	Overweight → Underweight	—	$38.07	$37.15	-2.4%	-2.3%	-2.2%	-1.6%	-1.2%	-1.8%
Nov 25	UBS	Upgrade	Neutral → Buy	—	$36.95	$36.29	-1.8%	-1.1%	+0.4%	+1.3%	+1.7%	+1.7%
Sep 2	RBC Capital	Downgrade	Outperform → Sector Perform	—	$35.77	$35.33	-1.2%	-0.8%	-3.0%	-2.5%	-4.4%	-3.1%
Jan 7	Morgan Stanley	Downgrade	Overweight → Equal Weight	—	$28.19	$28.15	-0.1%	+0.1%	-0.7%	-0.2%	+0.1%	+0.6%
Sep 23	Bernstein	Downgrade	Outperform → Market Perform	—	$32.05	$31.68	-1.2%	-0.2%	-1.4%	-3.6%	-5.8%	-4.5%
Aug 29	Morgan Stanley	Upgrade	Equal Weight → Overweight	—	$32.67	$32.78	+0.3%	+0.6%	-0.3%	-3.4%	-4.2%	-3.9%
Jul 29	RBC Capital	Upgrade	Sector Perform → Outperform	—	$31.66	$31.71	+0.2%	+0.3%	+0.3%	+1.2%	-0.8%	-2.2%
Jun 25	Redburn Atlantic	Upgrade	Neutral → Buy	—	$30.41	$30.48	+0.2%	+0.4%	-0.2%	+0.6%	+1.2%	+2.5%
Mar 20	Berenberg	Downgrade	Buy → Hold	—	$31.41	$30.92	-1.6%	-0.4%	-1.6%	-1.2%	+0.3%	-0.3%
Sep 22	JP Morgan	Upgrade	Neutral → Overweight	—	$31.70	$32.47	+2.4%	+2.0%	+2.0%	+0.7%	+2.5%	+2.4%
Jan 3	Bernstein	Upgrade	Market Perform → Outperform	—	$28.66	$29.12	+1.6%	+0.4%	+0.5%	+0.6%	+2.9%	+3.8%
Mar 23	Morgan Stanley	Downgrade	Overweight → Equal Weight	—	$28.83	$29.16	+1.1%	+1.3%	+1.6%	+3.1%	+1.3%	+1.9%
Mar 21	HSBC	Upgrade	Hold → Buy	—	$28.36	$28.96	+2.1%	+1.5%	+1.7%	+3.0%	+3.2%	+4.8%
Jan 4	Bernstein	Upgrade	Underperform → Market Perform	—	$28.17	$28.53	+1.3%	+1.2%	+1.3%	+2.3%	+3.8%	+2.2%
Jan 3	HSBC	Downgrade	Buy → Hold	—	$27.65	$28.06	+1.5%	+1.9%	+3.1%	+3.2%	+4.2%	+5.7%
Dec 1	Berenberg	Upgrade	Hold → Buy	—	$26.39	$27.12	+2.8%	-0.0%	+3.0%	+2.9%	+5.2%	+6.7%
Nov 19	Barclays	Upgrade	Underweight → Overweight	—	$28.22	$27.72	-1.8%	-2.6%	-1.9%	-0.4%	-1.3%	-6.8%
Oct 14	RBC Capital	Upgrade	Sector Perform → Outperform	—	$27.54	$27.99	+1.6%	+1.4%	+2.9%	+3.1%	+3.2%	+4.5%
Sep 17	JP Morgan	Upgrade	Underweight → Overweight	—	$25.91	$25.98	+0.3%	-1.4%	-5.6%	-3.9%	-1.7%	-0.6%
Jul 22	HSBC	Downgrade	Buy → Hold	—	$22.92	$22.95	+0.1%	-1.2%	-2.1%	+1.8%	+0.9%	+2.0%
Jul 21	HSBC	Downgrade	Buy → Hold	—	$22.41	$22.66	+1.1%	+2.3%	+1.1%	+0.2%	+4.1%	+3.2%
Apr 12	Jefferies	Upgrade	Hold → Buy	—	$24.31	$24.34	+0.1%	-0.9%	+0.4%	+2.6%	+2.5%	+2.2%
Apr 12	Credit Suisse	Upgrade	Underperform → Neutral	—	$24.31	$24.34	+0.1%	-0.9%	+0.4%	+2.6%	+2.5%	+2.2%
Mar 31	Morgan Stanley	Upgrade	Underweight → Overweight	—	$24.41	$24.66	+1.0%	+1.2%	+2.6%	+2.2%	+1.8%	+2.0%
Mar 15	HSBC	Upgrade	Hold → Buy	—	$24.96	$24.90	-0.2%	-0.8%	-2.4%	-0.4%	-3.0%	-2.8%
Jan 21	Jefferies	Maintains	Hold → Hold	—	$21.69	$21.47	-1.0%	-2.7%	-3.4%	-5.7%	-4.6%	-5.3%
Mar 9	Bernstein	Downgrade	Outperform → Market Perform	—	$22.81	$18.82	-17.5%	-21.8%	-15.9%	-21.5%	-34.9%	-28.7%
May 7	Citigroup	Downgrade	Buy → Neutral	—	$33.30	$32.68	-1.9%	-2.4%	-2.7%	-3.0%	-3.2%	-3.3%
Sep 11	Barclays	Downgrade	Equal Weight → Underweight	—	$36.68	$36.43	-0.7%	+0.8%	+1.4%	+2.4%	+1.5%	+2.6%
Sep 11	Berenberg	Maintains	Hold → Hold	—	$36.68	$36.43	-0.7%	+0.8%	+1.4%	+2.4%	+1.5%	+2.6%
Jul 19	Credit Suisse	Upgrade	Neutral → Outperform	—	$37.78	$37.46	-0.8%	-0.7%	-0.1%	+0.1%	+1.0%	+1.6%
May 17	Barclays	Upgrade	Underweight → Equal Weight	—	$39.02	$39.31	+0.7%	+0.2%	-0.4%	-3.0%	-3.4%	-4.4%
Nov 7	HSBC	Upgrade	Hold → Buy	—	$33.85	$34.09	+0.7%	+0.7%	+0.5%	+0.1%	-0.5%	-1.3%
Aug 21	Barclays	Downgrade	Equal Weight → Underweight	—	$31.31	$31.05	-0.8%	-0.6%	-1.2%	-0.4%	-0.6%	-0.1%
Jan 17	Jefferies	Upgrade	Hold → Buy	—	$33.15	$33.07	-0.2%	-0.3%	-0.6%	-0.6%	+0.3%	-1.1%
Jan 11	Exane BNP Paribas	Upgrade	Underperform → Neutral	—	$32.78	$32.68	-0.3%	+0.3%	+0.6%	+1.1%	+0.8%	+0.5%
Dec 5	Morgan Stanley	Upgrade	Underweight → Equal Weight	—	$28.75	$29.01	+0.9%	+1.7%	+4.1%	+5.0%	+5.3%	+4.5%
Nov 2	JP Morgan	Downgrade	Neutral → Underweight	—	$28.74	$28.62	-0.4%	-2.2%	-2.1%	-3.1%	-1.9%	-1.8%
Oct 5	Deutsche Bank	Upgrade	Hold → Buy	—	$28.94	$29.73	+2.7%	+2.7%	+2.5%	+2.4%	+4.3%	+1.5%
May 2	Societe Generale	Downgrade	Buy → Hold	—	$32.77	$32.21	-1.7%	-1.7%	-4.9%	-6.0%	-5.4%	-6.1%
Mar 21	RBC Capital	Upgrade	Sector Perform → Outperform	—	$31.05	$31.02	-0.1%	-0.6%	-0.5%	-3.5%	-4.4%	-4.8%
Mar 1	Barclays	Upgrade	Underweight → Equal Weight	—	$27.90	$28.93	+3.7%	+4.6%	+5.1%	+7.5%	+7.0%	+7.7%
Feb 29	Citigroup	Upgrade	Neutral → Buy	—	$27.72	$27.86	+0.5%	+0.6%	+5.3%	+5.7%	+8.2%	+7.7%
Jan 12	Jefferies	Upgrade	Underperform → Hold	—	$27.65	$28.00	+1.3%	+0.3%	-0.7%	+4.2%	-0.5%	-1.0%
Dec 2	Citigroup	Upgrade	Sell → Neutral	—	$32.31	$32.58	+0.8%	-0.3%	-0.5%	-1.6%	-4.2%	-7.0%
Nov 6	BTIG Research	Downgrade	Buy → Neutral	—	$32.07	$31.79	-0.9%	+0.7%	-0.4%	+0.3%	-0.9%	-3.1%
Nov 6	BTIG	Downgrade	Buy → Neutral	—	$32.07	$31.79	-0.9%	+0.7%	-0.4%	+0.3%	-0.9%	-3.1%
Nov 2	Morgan Stanley	Downgrade	Equal Weight → Underweight	—	$32.60	$32.65	+0.2%	+1.1%	+1.8%	-0.6%	-1.6%	-1.0%

Recent Filings

8-K · 7.01 ! Medium

Entera Bio Ltd. -- 8-K 7.01: Regulation FD Disclosure

Entera Bio advanced its osteoporosis candidate EB613 toward FDA approval by submitting a Phase 3 protocol, potentially positioning the company for a key registrational trial in a large market.

Mar 4

Data updated apr 26, 2026 10:23am · Source: massive.com